Skip to content
DataLookout
Menu

PROMETHEENCT07921719

PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Self-reported Smoking Cessation at 12 Months
Timeframe: 12 months

Arms and interventions

PROMETHEE Cohort

Participants enrolled in IMPULSION and referred to the PROMETHEE tele-tobacco platform. The pathway includes facilitated access to smoking cessation specialists, up to four follow-up teleconsultations, and systematic consideration of pharmacological cessation treatment.

Control Cohort

Matched IMPULSION participants receiving standard smoking cessation support according to local resources and the routine IMPULSION program

Other: PROMETHEE Cohort, Control Cohort

Sites

1 site in 1 country

  • Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Hôpital Lyon Sud, Hospices Civils de LyonPierre-Bénite, France